Loading...
AFT Pharmaceuticals Limited
AFP.AX•ASX
HealthcareDrug Manufacturers - Specialty & Generic
$2.45
$0.00(0.00%)
AFT Pharmaceuticals Limited (AFP.AX) Stock Overview
Explore AFT Pharmaceuticals Limited’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
25.41%
↑ 25.41%
Profit Growth
$0.11
↑ 46.51%
EPS Growth
$0.11
↑ 50.00%
Operating Margin
9.66%
↑ 29.79%
ROE
13.53%
↑ 46.51%
Dividend Yield
0.00%
Analyst Recommendations data is not available for AFP.AXAnalyst Recommendations details for AFP.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, eyecare, first aid, pain management, gastrointestinal, dermatology, and medicated vitamins. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.
CEO
Dr. Hartley Atkinson Ph.D.
Employees
110
Headquarters
129 Hurstmere Road, Auckland
Founded
2016